SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4.31 |
| Enterprise Value ($M) | 1.94 |
| Book Value ($M) | 2.13 |
| Book Value / Share | 0.32 |
| Price / Book | 2.03 |
| NCAV ($M) | 1.30 |
| NCAV / Share | 0.20 |
| Price / NCAV | 3.30 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.21 |
| Return on Assets (ROA) | -1.34 |
| Return on Equity (ROE) | -1.46 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.99 |
| Current Ratio | 1.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.63 |
| Assets | 3.45 |
| Liabilities | 1.32 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -8.28 |
| Net Income | -13.20 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -6.92 |
| Cash from Investing | 0.00 |
| Cash from Financing | 7.85 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | 101.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 5,595 | 57,584 | 9.72 | |
| 18,039 | 98,060 | 18.40 | |
| 82,836 | 303,827 | 27.26 | |
| 28,183 | 184,919 | 15.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACB – Aurora Cannabis Inc. | ACHV – Achieve Life Sciences, Inc. |
| ACXP – Acurx Pharmaceuticals, Inc. | ADTX – Aditxt, Inc. |
| ADVM – Adverum Biotechnologies, Inc. |
Financial data and stock pages provided by
Fintel.io